Concepedia

Kathy Lampl

KL

Statistics

Publications

23

Citations

1.3K

H-Index

17

Active since

1985

Affiliations

AstraZeneca (United States)(Current)

Cleveland Clinic

New York University

Center for Clinical Research (United States)

University of Pennsylvania

Kathy Lampl is an author at AstraZeneca (United States) specializing in medicine, asthma, and pediatrics.

Top concepts

Publications per year

1985–2024

23

Publications

23

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy

Milind Y. Desai, Anjali Owens, Jeffrey B. Geske et al. · Journal of the American College of Cardiology · 2022 · 319 citations · Full text

Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children

Kevin R. Murphy, Robert S. Zeiger, Mark Kosinski et al. · Journal of Allergy and Clinical Immunology · 2009 · 160 citations · Full text

, , +12

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction

Milind Y. Desai, Anjali Owens, Kathy Wolski et al. · JAMA Cardiology · 2023 · 133 citations · Full text

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

Anjuli Nayak, Charles H. Banov, Jonathan Corren et al. · Annals of Allergy Asthma & Immunology · 2000 · 86 citations

, , +3

Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks

Milind Y. Desai, Anjali Owens, Jeffrey B. Geske et al. · Circulation · 2022 · 84 citations

1–5 of 23